Chess Robert's Form 4 filing
Nektar Therapeutics (NKTR) · filed Sep 20, 2023
- Accession no.
- 0001209191-23-050222
- Filed
- Sep 20, 2023
- Trade date
- Sep 22, 2022-Sep 19, 2023
- Filing delay
- 363 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market sales total $6.83K. It was filed 363 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chess RobertCIK 0001227886 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2022 | Common Stock | SSaleDisposed | −10,200 | $0.67 | −$6,834 | 274,773 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 | Common Stock | AGrant or awardAcquired | +85,000 | $0.00 | $0 | 85,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.